𝔖 Bobbio Scriptorium

✦ LIBER ✦

Role of laparoscopic uterine artery coagulation in management of symptomatic myomas: A prospective study using ultrasound and magnetic resonance imaging

✍ Scribed by Simsek, Mehmet; Sadik, Salih; Taskin, Omur; Guler, Hayrettin; Onoglu, Ahmet; Akar, Munire; Kursun, Sinan; Tinar, Sivekar

Book ID: 122393635
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 272 KB
Volume: 13
Category: Article
ISSN: 1553-4650
DOI: 10.1016/j.jmig.2006.03.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Prospective Feasibility Study of Duple

A Prospective Feasibility Study of Duplex Ultrasound Arterial Mapping, Digital-Subtraction Angiography, and Magnetic Resonance Angiography in Management of Critical Lower Limb Ischemia by Endovascular Revascularization

✍ Lowery, A.J.; Hynes, N.; Manning, B.J.; Mahendran, M.; Tawfik, S.; Sultan, S. 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 293 KB

The role of imaging (neck ultrasound, ma

The role of imaging (neck ultrasound, magnetic resonance and positron emission tomography-computed tomography) in the management of the neck after chemo-radiotherapy in locally advanced head and neck cancer: Preliminary report of a prospective study

✍ R. Pellini; L. Marucci; A. Vidiri; G.M. Meduri; A. Di Marzol; G. Arcanoeli; G. S 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 229 KB

Can multiparametric magnetic resonance i

Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?11Mohamed Abd-Alazeez receives funding from the Egyptian government. Mark Emberton and Hashim U. Ahmed receive funding from USHIFU and Advanced Medical Diagnostics for clinical trials. Mark Emberton is a paid consultant for Steba Biotech, USHIFU and Sanofi-Aventis. Mark Emberton has received research support by GSK for a study evaluating the role of MRI in men with prostate cancer. Mark Emberton and Hashim Ahmed have previously received medical consultancy fees from GE Healthcare/Oncura and Hashim Ahmed previously from Steba Biotech. Mark Emberton is a medical director of Mediwatch PLC. Hashim Uddin Ahmed and Mark Emberton receive funding from the Medical Research Council, the NIHR-HTA, NIHR-i4i, the US NIH/NCI, Pelican Cancer Foundation, Prostate Cancer UK, and St Peter׳s Trust. This work was part funded by research support for Mark Emberton and Alex Kirkham from the UK National Institute of Health Research UCLH/UCL Comprehensive Biomedical Research Centre, London, UK.

✍ Abd-Alazeez, Mohamed; Ahmed, Hashim U.; Arya, Manit; Allen, Clare; Dikaios, Niko 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 415 KB